期刊文献+

尿脱落细胞Tenascin-c mRNA检测在膀胱癌诊断中的价值

The significance of the detection of Tenascin-c mRNA in exfoliated urothelial cells in the diagnosis of bladder cancer
下载PDF
导出
摘要 目的探讨尿脱落细胞Tenascin-c(TN-C)基因检测在膀胱癌诊断中的价值。方法采用逆转录聚合酶链反应(reverse transcription polymerase chain reaction,RT-PCR)半定量法检测32例膀胱癌患者、22例泌尿生殖系良性疾病患者和5例健康志愿者清晨新鲜尿尿脱落细胞Tenascin-c mRNA的表达水平,并与尿脱落细胞学检查相对照。结果用RT-PCR法检测尿脱落细胞Tenascin-c mRNA用于诊断膀胱癌的敏感性为81.3%,高于尿脱落细胞学检测(37.5%)(P<0.05),不同分化程度及不同临床病理分期膀胱癌患者之间尿脱落细胞Tenascin-c mRNA的阳性表达率的差异有统计学意义(P<0.05)。结论尿脱落细胞Tenascin-c mRNA的检测可作为膀胱癌早期诊断、复发监测的一项极其灵敏的方法,并有助于肿瘤分级分期的判断。 Objective To study the significance of the detection of Tenascin-c mRNA in exfoliated urothelial cells for the diagnosis of bladder cancer. Methods The fresh urine voided firstly in. the morning were collected from 32 patients with bladder cancer, 22 patients with benign urogenital diseases and 5 healthy volunteers. Tenascin-c mRNA expression was studied by mean of reverse transcriptase polymerase chain reaction (RT-PCR) with semiquantitative analysis in urine exfoliated cells, and controlled experiment was conducted by urinary cytology analysis. Results The sensitivity of Tenascin-c mRNA for urine exfoliated ceils was 81.3 %, which was signicantly higher than that of cytology examination (37.5 % ) (P〈0.05). There were significant different positive expression rates of Tenascin-c mRNA in urine exfoliated ceils from the bladder cancer patients with differrent grades or clinicopathological stages (P〈0.05). Conclusion RT-PCR assay to detect Tenascin-c mRNA in urine exfoliated cells is an extremely sensitive method for the early diagnosis and postoperative inspection of bladder cancer. It can help to identify the grade and stage of bladder cancer.
作者 谢胜 郝丽娜
出处 《现代泌尿外科杂志》 CAS 2008年第1期18-20,共3页 Journal of Modern Urology
关键词 膀胱肿瘤 尿脱落细胞 TENASCIN-C 逆转录聚合酶链反应(RT-PCR) bladder tumor urine exfoliated cell tenascin-c RT-PCR
  • 相关文献

参考文献8

  • 1Atula T, Hedstrom J, Finne P, et al. Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma [J]. Anticancer Res, 2003, 23(3C):3051-3056.
  • 2Maulard-Durdux C, Housset M. Prognostic factors of infiltrating tumors of the bladder FJ]. Cancer Radiother, 1998, 2(suppl 1) : 5-11.
  • 3李涛,王颖,陈梓甫,何延瑜,张延榕.尿细胞角蛋白在上尿路移行细胞癌诊断中的作用[J].现代泌尿外科杂志,2005,10(2):74-76. 被引量:5
  • 4Kalembeyi i, inada H, Nishiura R, et al. Tenascin-C upregulates matrix metalloproteinase-gin breast cancer cells: direct and synergistic effects with transforming growth factor betal [J]. int J Cancer, 2003, 105(1) :53-60.
  • 5Gazzaniga P, Nofroni i, Gandini O, et al. Tenascin C and epidermal growth factor receptor as markers of circulating tumoral cells in bladder and colon cancer [J]. Oncol Rep, 2005, 14(5) : 1199-1202.
  • 6刘红君,王佳丽,赵建忠,杨磊.膀胱移行细胞癌中Tenascin-C表达的研究[J].济宁医学院学报,2006,29(3):19-22. 被引量:1
  • 7Booth C, Harnden P, Selby PJ, et al. Towards defining roles and relationship for tenascin-c and TGF beta-1 in the normal and neoplasmic urinary bladder [J]. J Pathoh 2002, 198(3): 359- 368.
  • 8Jahkola T, Toivonen T, Von Smitten K, et al. Expression of teanascin in invasion border of early breast cancer correlates with higher risk of distant metastasis [J]. int J Cancer, 1996, 69(6): 445-447.

二级参考文献25

  • 1Sumi S, Arai K, Kitahara S, et al. Preliminary report of the clinical performance of a new urinary bladder cancer antigen test: comparison to voided urine cytology in thc detection of transitional cell carcinoma of the bladder [J]. Clin Chim Acta, 2000,296(1) :111-120.
  • 2Eissa S, Swellam M, Sadek M, et al. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors [J]. J Urol, 2002,168(2):465-469.
  • 3Sanchez-Carbayo M, Herrero E, Megias J, et al. Initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumor marker for transitional cell carcinoma of the bladder [J]. J Uro1,1999,161(4) :1110-1115.
  • 4Silen A, Rizvi SSH, Letocha H, et al. Evaluation of the UBC test in the urine of healthy individuals, patients with benign disorders and urinary bladder cancer [J]. Oncol Reports, 2000, 7(6): 1269- 1274.
  • 5Mian C, Lodde M, Haitel A, et al. Comparison of two qualitative assays, the UBC rapid test and the BTA stat test, in the diagnosis of urothelial cell carcinoma of the bladder [J]. Urology,2000, 56(2) :228-231.
  • 6Mian C, Lodde M, Haitel A, et al. Comparison of the monoclonal UBC-ELISA test and the NMP22 ELISA test for the detection of urothelial cell carcinoma of the bladder [J]. Urology,2000, 55(2) :223-226.
  • 7Giannopoulos A, Manousakas T, Gounari A, et al. Comparative evaluation of the diagnostic performance of the BTA stat test,NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors [J]. J Urol, 2001, 166(2):470-475.
  • 8Matteu Adams,J. Louise Jones, et al Changes in tenascin-C Isoform expression in invasive and preinvasive Breast Disease. Eur J Cancer Research, 2002,62: 3289
  • 9Jones FS, Jones PL. The tenascin family of ECM glycoproyein structure, function, and regulation during embryonic development and tissue remodellng.Dev Dyn,2000,218(2):235
  • 10Clark RA, Erickson HP, Springer TA. Tenascin supports lymphocyte rolling.J cell Boil, 1997, 137:755

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部